COVID-19 Sample Collection Kits Market Set to Surge Significantly During 2022 to 2030

 COVID-19 Sample Collection Kits Industry Overview

The global COVID-19 sample collection kits market size was valued at USD 6.48 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of (8.7)% from 2022 to 2030.

SARS-CoV-2 sampling is the most critical step in the effective diagnosis of active infection. False and imprecise specimen collection may lead to wrong or misleading test results. As a result, the Centers for Disease Control and Prevention (CDC) and other healthcare organizations have introduced standard procedures and guidance for effective specimen collection and streamlining the usage of COVID-19 sample collection solutions, thereby driving the market. In October 2021, the FDA granted Labcorp an Emergency Use Authorization (EUA) for a combination home collection kit that may detect COVID-19 plus influenza A/B in children as young as two years old. Those who match clinical standards, such as having symptoms, being contacted by someone with COVID-19, or being requested to be diagnosed by a health care physician, will receive the kit free of charge.

Gather more insights about the market drivers, restrains and growth of the Global COVID-19 Sample Collection Kits Market

The key stakeholders have collaborated with regional authorities and suppliers for preserving the manufacturing conditions and accelerating the company’s growth in swabs and the viral transport medium market. With the ongoing surge in demand due to the COVID-19 outbreak, companies are focusing on strategic products to maximize product output and supply. Moreover, there have been 424,822,073 confirmed cases of COVID-19 till February 2022, as per the WHO. As the number of COVID-19 cases rises, more COVID-19 collection kits are required, thereby boosting the growth of the market in the forecast period.

Furthermore, despite the high vaccination rate, contaminated patients can still transfer the disease, driving the transmission. Moreover, ongoing virus mutation generates variations in the viral structure, making vaccinations ineffective. As a result of these circumstances, demand for COVID-19 detection kits rises, boosting the total market growth.

The availability of swabs in various configurations for advanced infection detection is one of the key market drivers. For instance, in November 2020, researchers at the University of South Florida (USF) Health introduced a 3D printed nasal swab prototype for commercial usage. As of 25th November 2020, the organization has developed 100,000+ products, and hospitals across the globe have implemented their 3D files to develop tens of millions more swabs for use in a point-of-care setting.

Furthermore, the advent of antigen tests to fill the timeline and capacity gaps in the testing landscape is anticipated to spur the usage of Nasopharyngeal (NP) swabs across the globe. The U.S. government signed a USD 760 million deal with Abbott over its BinaxNOW COVID-19 Ag Card in August 2020. With this, the government aimed at tripling the national testing capacity. Such collaborations between the diagnostic players and government bodies are anticipated to greatly benefit the swab suppliers in the country.

In September 2021, Quidel Corporation has stated that their non-prescription QuickVue In-Home OTC corona-virus Test will be available to more than 7,000 CVS Pharmacy branches nationwide as well as online at cvs.com. Two self-administered fast antigen tests are included per shelf-stable packet.

Browse through Grand View Research's Clinical Diagnostics Industry Research Reports.

  • COVID-19 Antigen Test Market - The global COVID-19 antigen test market size was valued at USD 5.3 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.7% from 2021 to 2027. The COVID-19 antigen tests are gaining traction in the current scenario, as it is easy to use, patient-friendly, and has a shorter test-to result timeline.
  • COVID-19 Saliva Screening Test Potential Market - The global COVID-19 saliva screening test potential market size was valued at USD 2955.9 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 4.8% from 2021 to 2023.

COVID-19 Sample Collection Kits Market Segmentation

Grand View Research has segmented the global COVID-19 sample collection kits market based on product, application, site of collection, and region:

 

  • COVID-19 Sample Collection Kits Product Outlook (Revenue, USD Million, 2020 - 2030)
  • Swabs
    • Nasopharyngeal (NP) swabs
    • Oropharyngeal (OP) swabs
    • Nasal Swabs
  • Viral Transport Media
  • Blood Collection Kits
  • Other Consumables

 

  • COVID-19 Sample Collection Kits Application Outlook (Revenue, USD Million, 2020 - 2030)
  • Diagnostics
  • Research

 

  • COVID-19 Sample Collection Kits Site of Collection Outlook (Revenue, USD Million, 2020 - 2030)
  • Hospitals & Clinics
  • Home Test

 

  • COVID-19 Sample Collection Kits Regional Outlook (Revenue, USD Million, 2020 - 2030)
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 

Market Share Insights

  • September 2021: Quidel Corporation has stated that their non-prescription QuickVue In-Home OTC corona-virus Test will be available to more than 7,000 CVS Pharmacy branches nationwide as well as online at cvs.com. Two self-administered fast antigen tests are included per shelf-stable packet.
  • November 2020: Puritan received a fund of USD 11.6 million for the expansion of its swab manufacturing capabilities to meet the supply of 3 million swabs per month. 
  • November 2020: researchers at the University of South Florida (USF) Health introduced a 3D printed nasal swab prototype for commercial usage. 

 

Key Companies profiled:

Some prominent players in the global COVID-19 sample collection kits market include

  • Puritan Medical Products
  • COPAN Diagnostics
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific, Inc.
  • Laboratory Corporation of America Holdings
  • Lucence Diagnostics Pte Ltd.
  • Hardy Diagnostics
  • Trinity Biotech
  • Quidel Corporation
  • Quest Diagnostics
  • Danaher Corporation
  • Vitagene Inc.
  • Formlabs
  • HiMedia Laboratories
  • VIRCELL S.L.

 

Order a free sample PDF of the COVID-19 Sample Collection Kits Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

 

 

 

 

 

 

Comments

Popular posts from this blog

Global Potash Market: Trends, Growth & Forecast 2023-2032

Smart Ticketing Market Report: Emerging Technologies & Market Opportunities

Boosting Crop Yields: India Foliar Fertilizer Market Trends & Forecasts